NEW YORK (GenomeWeb) – Opko Health yesterday reported a massive jump in third quarter revenues as the company benefitted from its recent acquisitions of clinical lab Bio-Reference Laboratories and specialty pharmaceutical manufacturer EirGen earlier this year.

For the three-month period ended Sept. 30, Miami, Florida-based Opko reported consolidated revenues of $143 million compared with $19.8 million in the same period last year, in line with analysts' consensus estimate. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.